Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference61 articles.
1. Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response;Hombach-Klonisch;Pharmacol. Ther.,2018
2. Circulating tumor stem cells and glioblastoma: a review;van Schaijik;J. Clin. Neurosci.,2019
3. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas;Zhang;Stem Cell Res. Ther.,2018
4. Patterns of invasive growth in malignant gliomas – the hippocampus emerges as an invasion-spared brain region;Mughal;Neoplasia,2018
5. Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma;Sekerdag;J. Neurol. Sci.,2017
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances;Recent Patents on Biotechnology;2024-03
2. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment;Biomedicine & Pharmacotherapy;2024-02
3. Tadpole-Like Anisotropic Polymer/Lipid Janus Nanoparticles for Nose-to-Brain Drug Delivery: Importance of Geometry, Elasticity on Mucus-Penetration Ability;Molecular Pharmaceutics;2024-01-02
4. Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions;Pharmaceutical Development and Technology;2023-11-26
5. Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models;Journal of Advanced Research;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3